Calendar Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
3.25 USD +2.52% Intraday chart for Leap Therapeutics, Inc. +16.07% -21.59%

Chart calendar Leap Therapeutics, Inc.

d9308ba5c339572f09cd01d92da.ehJ9Hx9D_ZIETnWgWyN8FZMjuQFAUdQhOanMAKeCfHk.M1wXTiYBluN2dzbYMxA5d8Zh0HNtNOd1WNH9UZ7EOx40Xhd4bDKe5kU3RQ~acff08d9c521eef36086acc8b92add9a

Upcoming events on Leap Therapeutics, Inc.

15/05/2024 Q1 2024 Earnings Release (Projected)
09/08/2024 Q2 2024 Earnings Release (Projected)
14/11/2024 Q3 2024 Earnings Release (Projected)
24/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Leap Therapeutics, Inc.

18/03/2024 04:30 pm Q4 2023 Earnings Release
23/01/2024 07:00 pm Business Update Call
20/01/2024 05:00 pm American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 104
18/01/2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
11/01/2024 03:00 am JPMorgan Healthcare Conference
28/11/2023 06:30 pm Piper Sandler Healthcare Conference
13/11/2023 05:30 pm Q3 2023 Earnings Release
14/09/2023 12:40 am Baird Global Healthcare Conference
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
14/08/2023 04:30 pm Q2 2023 Earnings Release
16/06/2023 Annual General Meeting
05/06/2023 10:00 pm American Society of Clinical Oncology Conference - Abstract Number: 4027
15/05/2023 04:30 pm Q1 2023 Earnings Release
24/03/2023 04:30 pm Q4 2022 Earnings Release
16/03/2023 Extraordinary Shareholders Meeting
19/01/2023 12:00 am B. Riley Securities Oncology Conference
17/01/2023 07:30 pm Acquisition of Flame Biosciences, Inc. by Leap Therapeutics, Inc. Call
30/11/2022 02:30 am Piper Sandler Healthcare Conference
14/11/2022 05:30 pm Q3 2022 Earnings Release
10/11/2022 07:30 pm Society for Immunotherapy of Cancer Meeting - Abstract Number: 553

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
1,50
1,70
-11.76%
1,50
1,52
-1.63%
0,00
1,20
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-33,5
-32,7
-2.32%
-28,5
-30,7
6.95%
-41,4
-43,0
3.62%
-56,8
-55,9
-1.62%
-87,0
-87,9
0.95%

-71,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-32,9
-32,5
-1.23%
-27,5
-35,4
22.37%
-40,6
-41,1
1.07%
-54,4
-55,2
1.33%
-81,4
-83,8
2.86%

-69,8

Net income
Million USD
Released
Forecast
Spread
-33,3
-32,5
-2.33%
-37,6
-40,5
7.15%
-40,6
-41,1
1.13%
-54,6
-55,2
1.07%
-81,4
-83,8
2.86%

-69,8

EPS
USD
Released
Forecast
Spread
-14,7
-14,2
-3.52%
-6,30
-6,40
1.56%
-4,70
-4,92
4.47%
-4,80
-4,88
1.64%
-3,98
-3,50
-13.71%

-2,25

Announcement Date16/03/2012/03/2111/03/2224/03/2318/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,38
0,30
23.03%
0,00
0,15
-
0,00
0,00
-
0,00
0,00
-
0,00
1,20
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-10,5
-12,0
12.9%
-10,6
-11,3
5.59%
-16,9
-11,0
-53.35%
-15,3
-13,3
-15.03%
-13,9
-13,0
-6.93%
-42,7
-14,4
-196.56%
-14,7
-14,2
-3.11%
-14,8
-15,2
2.1%
-14,8
-15,7
5.31%

-16,1


-17,2


-18,3


-19,6


-18,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,8
-11,3
3.9%
-10,4
-11,0
5.77%
-17,0
-10,9
-56.83%
-15,1
-13,2
-14.29%
-12,0
-12,8
6.87%
-41,9
-13,4
-211.67%
-13,4
-13,6
1.74%
-13,7
-14,2
3.37%
-12,5
-14,9
16.13%

-15,7


-16,8


-18,0


-19,2


-17,2

Net income
Million USD
Released
Forecast
Spread
-10,8
-11,3
4.11%
-10,4
-11,0
5.77%
-17,0
-10,9
-56.83%
-15,1
-13,2
-14.29%
-12,1
-12,8
5.72%
-41,9
-13,4
-211.67%
-13,4
-13,6
1.74%
-13,7
-14,2
3.37%
-12,5
-14,9
16.13%

-15,7


-16,8


-18,0


-19,2


-17,2

EPS
USD
Released
Forecast
Spread
-0,80
-1,10
27.27%
-0,90
-1,00
10%
-1,50
-0,96
-56.25%
-1,30
-1,18
-10.17%
-1,00
-1,10
9.09%
-3,20
-0,86
-272.09%
-0,91
-0,90
-1.56%
-0,51
-0,58
11.76%
-0,20
-0,56
63.96%

-0,59


-0,62


-0,62


-0,49


-0,40

Announcement Date11/03/2213/05/2212/08/2214/11/2224/03/2315/05/2314/08/2313/11/2318/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LPTX Stock
  4. Calendar Leap Therapeutics, Inc.